Exposure to per- and polyfluorinated alkyl substances in pregnant Brazilian women and its association with fetal growth
By Marilia Cristina Oliveira Souza, Maria Conceição Pereira Saraiva, Masato Honda, Marco Antônio Barbieri, Heloisa Bettiol, Fernando Barbosa, and Kurunthachalam Kannan
May 5, 2020
Research pertaining to exposure of humans to per- and polyfluorinated alkyl substances (PFASs) has received considerable public and regulatory attention in recent years. Although several studies have reported exposure to PFASs by populations in North America and western Europe, such information is still scarce in Latin America, including Brazil. In this study, concentrations of thirteen PFASs were determined in whole blood collected during the second trimester from 252 pregnant Brazilian women. This is a nested case-control study within the Brazilian Ribeirao Preto and Sao Luiz Birth Cohort Study (BRISA) with selected birth outcomes cases (n = 63) and matched controls (n = 189). PFASs concentrations were associated with conditions including preeclampsia, birth weight (BW), preterm birth, and intrauterine growth restriction (IUGR). Among PFASs measured, perfluorooctane sulfonate (PFOS) was found at the highest concentration (range: 1.06–106 ng mL−1 with a median value of 3.41 ng mL−1) which was followed by perfluorooctanoic acid (PFOA, range: 0.11–2.77 ng mL−1 with a median value of 0.20 ng mL−1). A significant positive association of PFOS and PFOA concentrations with fetal growth restriction (p < 0.05) was found. This is the first study to assess whole blood concentrations of PFASs and their effect on fetal growth in pregnant Brazilian women.